Molecular Diagnostics Testing
Control. Simplicity. Better Outcomes.
Siemens Healthineers Atellica™ portfolio of molecular and immunoassay testing systems offer a total solution for the effective treatment and management of a wide range of infectious diseases. Learn about the NEW Atellica MDX 160 Molecular System*, a flexible molecular diagnostics platform that offers one solution and more choice for Siemens assays (HIV, HBV, HCV, CT/GC), and immunosuppression assays (CMV, EBV, HHV-6, HSV 1 and 2, Parvovirus B19, Adenovirus, BKV, JCV, VZV)** as well as other manufacturers’ assays and laboratory-developed tests.
Atellica MDX 160 Molecular System
The NEW Atellica MDX 160 Molecular System: A powerful automation solution that provides flexibility and highly accurate results for a broad range of molecular tests, including HIV, HBV, HCV, CT/GC, Immunosuppression, and more.
The Atellica MDX 160 Molecular System is a flexible, automated molecular system that delivers maximum productivity to your laboratory. The new system has a growing IVD menu, including other manufacturers’ assays and laboratory-developed tests (LDTs), and supports extraction of nucleic acids from multiple sample types.
Our proprietary extraction technology and open-channel system gives laboratories the flexibility to develop their own protocols for extraction, amplification, and detection of nucleic acids from a wide variety of targets. The innovative Atellica MiPLX Software Solution enhances workflow by automating extraction and PCR plate set-up as well as enabling simultaneous testing of up to six assays per run from a single patient sample. New tailored dynamic configurations further enhance flexibility and workflow efficiency by offering a range of testing protocols and fully-tailored workflows. With the new Siemens system, users can now choose from a variety of testing strategies including: flexible multiplex testing, PCR plate set-up or nucleic acid extraction.
The Atellica MDX 160 Molecular System combines the performance, easy-to-use automation, and small footprint of the Atellica MDX 160 Sample Prep and the Thermo Fisher QuantStudio 5 Thermal Cycler*. The user-friendly system reduces manual labor, allowing personnel to spend time on other value-added activities, while providing outstanding assay performance and choice with a broad IVD menu including HIV-1, HBV, HCV viral load, CT/GC detection, and nine immunosuppression qualitative and quantitative assays: CMV, EBV, HSV-1 and 2, HHV-6, Adenovirus, VZV, BKV, JCV, and Parvovirus B19.
Experience the power of a revolutionary diagnostic system engineered to deliver control and simplicity, so you can drive better outcomes.
Learn more about the Atellica MDX 160 Molecular System
Learn more about VERSANT kPCR IVD Assays
Learn more about VERSANT HCV Genotype 2.0 Assay (LiPA) (Now FDA-approved in the US!)
*Under development. Not for sale. Product availability will vary by country.
**CE-marked for IVD use. kPCR PLX assays are manufactured by altona Diagnostics GmbH and distributed by Siemens Healthcare Diagnostics Inc.
ATELLICA and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners. Product availability may vary from country to country and is subject to varying regulatory requirements.